Kalamos

Dutch (Netherlands)

English (Belgium)

French (Belgium)

French (Global)

Madeleine Dembour

Kalamos, l'agence RP des PME qui ont des choses à direVisitez les newsrooms de nos clients :Communiqués récentsRecent press releasesRecente persberichtenA-MansiaBe WaPP - Wallonie Plus PropreDeroanneFoyer de la Région de FléronInvestsudPlastimobileVIVESWorldSkills Belgium

Kalamos, l'agence RP des PME qui ont des choses à direVisitez les newsrooms de nos clients :Communiqués récentsRecent press releasesRecente...

Kalamos, l'agence RP des PME qui ont des choses à direVisitez les newsrooms de nos clients :A-MansiaBe WaPP - Wallonie Plus PropreDeroanneFoyer de la Région de FléronInvestsudPlastimobileVIVESWorldSkills Belgium

Kalamos, l'agence RP des PME qui ont des choses à direVisitez les newsrooms de nos clients :A-MansiaBe WaPP - Wallonie Plus PropreDeroanneFoyer de...

#374151

The company from Ghislenghien aims to become one of the largest vertical farms in the world dedicated to the cultivation of medicinal plants.

Botalys raises 6,6 millions euros

The Walloon company Botalys, a world pioneer in the cultivation of medicinal plants using vertical precision farming, has raised €6.6 million in funding.

to deploy its new concept of environmental camera

The Walloon start-up “VOCSens” raises €2.5 million

[Communiqué en français - Persbericht in het Nederlands]

In an increasingly digital world, every click is an income potential! However, the ad industry remains shy regarding podcasts: audience numbers are still unclear. NeuroMedia Software, a start-up specialised in audience measurement, launches a certification service.

NeuroMedia Software launches certification of podcast audiences

The Walloon SME NeuroMedia launches a novel tool for measuring radio and TV audiences

Towards a “Shazam” for radio

Dual designations granted for NVD-003 for the Treatment of Congenital Pseudarthrosis of the Tibia a serious and debilitating condition that primarily affects children

Novadip Biosciences Receives Rare Paediatric Disease Priority Review and Orphan Disease Designation

Acquisition of a stake by Wallimage Entreprises and Investsud

Raising of equity for the Walloon SMB NeuroMedia

[Persbericht in het Netherlands - Communiqué de presse en français]

Launch of a joint research group Kaneka - Eurogentec - UCLouvain

University of Louvain bacteria research appeals to Japan

July 1, 2020 - The UCLouvain created, through its technology transfer office Sopartec, a new European university fund of €32m, VIVES Inter-University Fund. Its ambition? Accelerate the transformation of research into a societal benefit. The fund offers a unique ecosystem with incubators and university hospitals, providing albeit a powerful cross-border innovation network useful to start-ups.

VIVES III: a new European inter-university fund of €32M to accelerate innovation

UCLouvain created, through its technology transfer company Sopartec, a new European inter-university fund of €32M. Its ambition? A total fund of €50M. The fund will be named VIVES Inter-University Fund. The fund may invest in spin-offs of five European universities ranked amongst the world’s top: l’UCLouvain and KULeuven (both, BE), l’Université de Paris (FR), Wageningen Universiteit (NL), l’Université du Luxembourg (LU). The new fund succeeds VIVES I and VIVES II, launched by UCLouvain in 2004 and 2011, respectively, and which led to 27 investments and a cumulated funding of €600M, i.e. 15x the stake of VIVES I and VIVES II.

Vives, Noshaq, QBIC, Gesval and the other shareholders of SmartNodes annonce their exit of the spin-off ULiege-UCLouvain.

Vives, Noshaq and QBIC sell their participation in SmartNodes to Lacroix Group, european leader in "Smart cities"

Smartnodes proposes a breakthrough innovation in public lighting solutions. Smartnodes creates a light bubble that perfectly fits in size and light intensity around the user (pedestrian, bike, car). The control of this light bubble is dynamic, decentralised and locally distributed.

Belgium, 17 January 2019 – A-Mansia Biotech, a microbiome company, has announced the appointment of Cees de Jong as the Chairman of its Board of Directors. His experience of successfully managing several companies of international standing in the life sciences sector strengthens A-Mansia in its ambition to launch new products in the field of metabolism.

Cees de Jong: new Chairman of the joint start-up A-Mansia Biotech

With a passion for health (1988, graduated as Medical Doctor at the University of Rotterdam) and for Business Management (1989, MBA Rotterdam), Cees de Jong boasts an exceptional professional path through both these domains. Throughout his career, he has played a key role in several major international companies. For the last five years, Mr de Jong has been the CEO of Chr. Hansen. Under his leadership, this flagship of the Danish economy was transformed into a true international player specialised in innovative bacteria-based solutions. With a workforce of more than 3,500 people in more than 30 countries, Chr. Hansen has witnessed growth in excess of 10% a year since 2014. Presently, it is the intention of Mr. de Jong to continue his career in a support and advisory role to various innovative companies.